Found 0 matching trials
GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma
PHASE2This prospective, multicenter study evaluates a response-adapted treatment ...
Location
Fudan University Shanghai Cancer Center
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
PHASE3Nasopharyngeal carcinoma (NPC) is a geographically endemic, Epstein-Barr vi...
Location
Kaohsiung Veterans General Hospital.
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
PHASE2Natural killer/T-cell lymphoma (nasal type) is a mature T/NK-cell lymphoma ...
Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL
PHASE2Aim of the trial is to evaluate the safety and efficacy of sintilimab and p...
Location
Sun Yat-sen University Cancer Center
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
NAThis study is a prospective, self-controlled, multicenter clinical trial. A...
Location
The Fifth Affiliated Hospital of Sun Yat-sen University
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
N/A1. To determine the prognostic implication of plasma Epstein-Bar Virus (EBV...
Location
Stanford University School of Medicine
Infections and Unexplained Infertility
N/A1. Background: In women, unexplained infertility has been associated with a...
Location
Multiple Locations
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
N/AThe investigators intend to compare Epstein-Barr virus antibody and Epstein...
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis
N/AThe purpose of this study is to determine if the screening of nasopharyngea...
Location
Chinese University of Hong Kong
Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC
N/APET/CT and EBV DNA are important in diagnosis of NPC. We consider that comb...
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center